CXCL10 and infection: Specifically, NDDS against SARS-CoV-2 can be designed to interact with viral RNA genome, surface S protein, IL 6, IFN γ-inducible protein 10 (IP-10/ CXCL10), immunoreceptor tyrosine-based activation motif (ITAM) or MCP1, in order to inhibit viral replication and infection.